AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03029559 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory Threshold Loading
Description: Subjects will undergo inspiratory threshold loading using a commercially available Threshold IMT device (Power breathe®). ITL will be administered at an intensity of 80% of the individual's maximal inspiratory pressure (MIP). The subjects will be instructed to take 10 deep, forceful breaths through the threshold device followed by at least 2 minutes of rest. The process will be repeated 4 more times for a total of 5 sets of 10 breaths each.
Study NCT03029559 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Intermittent Hypoxia
Description: Subjects will be exposed to a session of sham Intermittent hypoxia.This will consist of breathing room air for 45 minutes through a hypoxicator.
Study NCT03029559 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham Intermittent Hypoxia
Description: Subjects will be exposed to a session of sham Intermittent hypoxia.This will consist of breathing room air for 45 minutes through a hypoxicator.
Study NCT02379949 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exposure Group Therapy
Description: Exposure Group Therapy a behavioral treatment for social phobia. Participants face their fears by giving speeches to other group members.
Study NCT00283725 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Patients will be prescribed either galantamine or no AD treatment (ie, neither an acetylcholinesterase inhibitor \[AChEI\] nor memantine).
Study NCT00068055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omr-lgG-am
Description: Omr-IgG-am™ 5% is provided in 100 ml bottles (5.0 grams) as a sterile solution containing 5% protein, 10% maltose and water for injection. This product is licensed in Israel, but not in the US.
Study NCT00068055 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polygam® S/D
Description: Polygam® S/D is a solvent/detergent treated, sterile, freeze-dried preparation of highly purified immunoglobulin G (IgG) derived from large pools of human plasma. When reconstituted (5%) with the supplied diluent (sterile water for injection, USP) Polygam® S/D contains approximately 50mg of protein per ml (approximately 90% is gamma globulin); 3mg/ml human albumin, 22.5 mg/ml glycine, 20 mg/ml glucose, 2mlg/ml polyethylene glycol (PEG), 1 mcg/ml tri-nbutyl phosphate, 1 mcg/ml octoxynol 9, and 100 mcg/ml polysorbate 80.
Study NCT00068055 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal Saline.
Study NCT02451826 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ulipristal acetate
Description: CVR delivering Ulipristal acetate and one tablet levonorgestrel.
Study NCT04662346 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Difficulty score system for robotic pancreatoduodenectomy
Description: calculate the score for patient in you cohort
Study NCT02472665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: plasma-derived FVIII/VWF concentrate
Description: 1 single dose of 80 IU/kg VWF:RCo of Fanhdi will be administered
Study NCT02100592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early rehabilitation treatment on Erigo Hocoma
Description: 5 weekly sessions of erigo for three weeks. Expected tilt angle up to 60 °
Study NCT02100592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early rehabilitation treatment on Erigo Hocoma
Description: Early verticalization treatment with Erigo Hocoma, a tilt table with stepping system
Study NCT01565993 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hemoclip
Description: A rotatable clip-fixing device Quickclip 2 standard was used (Olympus Medical Systems Corp. Hachioji-shi, Tokyo, Japan), with an opening diameter of 135º and a maximum insertion portion diameter of 2.6 mm
Study NCT01565993 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Polipectomy
Description: Disposable electrosurgical snares (Olympus Medical Systems Corp. Hachioji-shi, Tokyo, Japan) and an electrosurgery unit ERBE (ERBE Elektromedizin GmbH, Germany) were used for polyp resection
Study NCT01960231 — intervention group
Intervention type: OTHER
Intervention: OGTT
Study NCT00003545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nelarabine
Study NCT06503835 — intervention group
Intervention type: PROCEDURE
Intervention: Fluoroscopy Guided Transforaminal Epidural Ozone Injection
Description: All procedures were performed under light sedation in a sterile operating room. Ozone was created by an ozone generator (Dr. J. Hänsler Ozonosan, Iffezheim, Germany). Appropriate diffusion of the non-ionic contrast agent into the periradicular and epidural area was verified through anteroposterior and lateral fluoroscopic images and the injections were then safely performed. Patients who underwent transforaminal epidural steroid plus ozone injection received additionally 5ml of ozone at a concentration of 28 g/ml for each transforaminal epidural injection level.
Study NCT06503835 — intervention group
Intervention type: PROCEDURE
Intervention: Fluoroscopy Guided Transforaminal Epidural Steroid Injection
Description: All procedures were performed under light sedation in a sterile operating room.Appropriate diffusion of the non-ionic contrast agent into the periradicular and epidural area was verified through anteroposterior and lateral fluoroscopic images and the injections were then safely performed. Patients who underwent transforaminal epidural steroid injection received two mL of dexamethasone (8 mg) and 3 mL of saline for each transforaminal epidural injection level
Study NCT03323905 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Symphony MRI guided High Intensity Focused Ultrasound (HIFU)
Description: The use of the MRI-HIFU for the ablation of leiomyomas
Study NCT01824303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LiRIS 400 mg
Description: LiRIS 400 mg contains lidocaine which is gradually released into the bladder over 14 days.
Study NCT01824303 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: LiRIS Placebo
Description: LiRIS Placebo contains lactose, inactive substance.
Study NCT02100267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methacholine Chloride (SK-1211)
Description: Subjects received saline and 0.039-25 mg/mL of Methacholine chloride
Study NCT03614013 — intervention group
Intervention type: OTHER
Intervention: Immunotherapy responders/non-responders
Description: paraffin samples will be collected retrospectively along with clinical data
Study NCT04496921 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin K supplementation, dose #1
Description: Vitamin K supplement : 2mg, once a day, for 6 months. Complete biochemical profile, weight and size (body mass index), drugs list, pulmonary function by spirometry (FEV, etc.). Food frequency questionnaire.
Study NCT04496921 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin K supplementation, dose #2
Description: Vitamin K supplement : 7mg, twice a week, for 6 months. Complete biochemical profile, weight and size (body mass index), drugs list, pulmonary function by spirometry (FEV, etc.). Food frequency questionnaire.
Study NCT02755675 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 68Ga-NOTA-AE105 PET/CT
Description: Following injection of 68Ga-NOTA-AE105 the patients will be subjected to PET/CT
Study NCT01049919 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bone marrow concentration device
Description: Concentration of autologous bone marrow aspirate for intramuscular delivery to affected limb
Study NCT01049919 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Placebo procedure (sham)
Description: Sham bone marrow aspiration, sham delivery to affected limb
Study NCT01751464 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WrapAround Case Management
Description: Youth Injured by Violence will be paired with a support worker who has extensive experience working with youth affected by violence.It is important to note that the wraparound concept involves individualized care planning and management. As such, the specific care plan will be different for each participant. Through early intensive meetings, they will develop a mentoring relationship. They will work with the youth to develop a support team, which may include family, teachers, child welfare workers and truly anyone the youth has decided can help them in their path to making positive choices.
Study NCT02634294 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peg interferon alfa-2b
Description: Eligible patients were treated with pegylated interferon alpha-2b (Peg Intron®; Schering-Plough (Brinny) Company, Innishannon, County Cork, Ireland) 1\~1.5ug/kg qw, until occurrence of grade II or higher grade of acute graft versus host disease, or no response to treatment after 8 doses of treatments.
Study NCT00901329 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NexGen Gender Fixed Bearing Knee prosthesis
Description: new female prosthesis
Study NCT00901329 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NexGen LPS-Flex Fixed Bearing Knee prosthesis
Description: standard knee prosthesis
Study NCT05521893 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine care
Description: In the telemedicine group, the appointments are performed online via scheduled videoconferences, on a monthly basis.~All women in the telemedicine group receive a smartphone with the installed application that enable transfer of the measured capillary glucose concentration.
Study NCT05521893 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: In the standard care group, visits are scheduled at the diabetes clinic on a monthly basis.
Study NCT01276327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linagliptin + Pioglitazone
Description: Medium doses, oral administration
Study NCT02811965 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Offloading Device B
Description: Heel offloading device that utilizes pressure absorbing filling to offload the heel. Device has a published clinical study demonstrating effectiveness at reducing heel ulceration rate
Study NCT02811965 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Offloading Device C
Description: Heel offloading device that utilizes a similar pressure absorbing filling to Offloading Device B; however this device does not have published clinical literature demonstrating effectiveness at reducing heel ulceration in the clinic.
Study NCT04181697 — intervention group
Intervention type: DEVICE
Intervention: PA measurement with Fitbit Charge 3
Description: Measurement of PA with Fitbit for all participants and controls.
Study NCT04181697 — intervention group
Intervention type: DEVICE
Intervention: PA measurement with Fitbit and ActiGraph GT3X
Description: Measurement of PA with ActiGraph for a subgroup of 20 participants.
Study NCT00944125 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dual Site LV Pacing
Description: Dual Site LV Pacing vs. BiV Pacing for a total of six months which includes two three crossover periods.
Study NCT00944125 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BiV Pacing
Description: Dual Site LV Pacing vs. BiV Pacing for a total of six months which includes two three crossover periods.
Study NCT03285152 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD)
Description: specially-formulated very low carbohydrate meals (KD)
Study NCT03285152 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Diet (SD)
Description: counseling on maintaining adequate nutritional intake from a normal diet (SD)
Study NCT02700217 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bupivacaine and Diamorphine
Study NCT02700217 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil, Propofol and Cistracurium
Study NCT02700217 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Remifentanil, Propofol and Cistracurium
Study NCT02700217 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine and Rectus Sheath injection
Study NCT02548156 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Test Dentifrice
Description: Marketed dentifrice containing 1150ppm fluoride and 5% w/w KNO3
Study NCT02548156 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Reference Dentifrice
Description: Marketed dentifrice containing 1150ppm fluoride and 5% w/w KNO3
Study NCT02548156 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Comparator Dentifrice
Description: Marketed dentifrice containing 1150ppm fluoride and 5% w/w KNO3
Study NCT02548156 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Orange Juice
Description: Teeth will be rinsed with orange juice followed by rinsing with de-ionised water in test dentifrice and comparator dentifrice arms.
Study NCT02548156 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: De-ionised water
Description: Teeth will be rinsed with de-ionised water followed by reference dentifrice and followed by rinsing with orange juice in test dentifrice and comparator dentifrice arms.
Study NCT03243110 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: breathing test
Description: Spirometry is a non-invasive means of measuring lung function: The participant is asked to take a deep breath and then exhale into the sensor as hard and as long as possible. Soft nose clips may be used to prevent air escaping through the nose. If the participant does not show a definitive diagnosis of asthma, a methacholine challenge test will be performed to elicit bronchoconstriction in participants. In methacholine challenge test, the participant breaths in standardized dose of nebulized methacholine again. Methacholine challenge test is widely accepted and standardized method for assisting the diagnosis of asthma and there will be no experimental altercation in the method methacholine challenge is performed.
Study NCT03871543 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: AquaComfort Plus
Description: Test Lens 1
Study NCT03871543 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Acuvue Oasys 1-Day
Description: Test Lens 2
Study NCT02671838 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Musculoskeletal ultrasound program
Description: Using a musculoskeletal ultrasound program to help improve medication adherence
Study NCT02743325 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SVT ablation by ALARA protocol
Description: Catheter ablation is a procedure that uses radiofrequency energy (similar to microwave heat) to destroy a small area of heart tissue that is causing arrhythmias. Destroying this tissue helps restore your heart's regular rhythm. The usage of CartoUnivuTM allows a seamless combination of a fluoro image and Carto® 3 System maps into a single view.
Study NCT02743325 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SVT ablation by conventional protocol
Description: Catheter ablation is a procedure that uses radiofrequency energy (similar to microwave heat) to destroy a small area of heart tissue that is causing arrhythmias. Destroying this tissue helps restore your heart's regular rhythm. The convention Ablation procedure works without a 3D navigation System.
Study NCT02767167 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Semi-skimmed cow's milk
Description: 430ml of semi-skimmed cow's milk / day for 12 weeks
Study NCT02172443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tiotropium inhalation powder capsules
Study NCT02172443 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atrovent
Study NCT02172443 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo to Atrovent
Study NCT02172443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo to tiotropium inhalation capsules
Study NCT02976129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: V565
Description: Daily dosing of V565 three times a day orally for 6 weeks
Study NCT01600612 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: carbetocin
Description: 10 ug of carbetocin will be given intravenously to patients with atonic postpartum hemorrhage
Study NCT01600612 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: misopristol
Description: 600 ug of misopristol will be given sublingually to patients with atonic postpartum hemorrhage
Study NCT01600612 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oxytocin
Description: 30 IU of oxytocin will be given intravenously to patients with atonic postpartum hemorrhage
Study NCT01510587 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 4-Health Educational curriculum
Description: During the intervention, parents meet about every 3 weeks (90 min/session) in small groups with facilitators. During meetings classroom activities aim to integrate 3 areas: 1) parents' knowledge about healthy diets, physical activity and improved body image; 2) parents' understanding, skills and potential roles as positive change-agents (i.e., parenting and behavior management); and 3) parents' learning and practicing cognitive-behavioral exercises that encourage specific skills within the family/home setting. Between monthly meetings, participants explore a suggested online websites or facilitator-assigned questions and provide feedback. The majority of outside time/assignments for parents is spent doing take-home activities with their preteen child and family.
Study NCT01510587 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Living Information
Description: During the Healthy Living Information intervention, participants receive packets delivered to their homes by mail at intervals similar to the meeting intervals for the educational curriculum intervention. (10 total packets.) Approximately every three weeks between late September 2011 and April 2012, corresponding approximately to the meeting times for the 4-Health Educational Program, participants in the Healthy Living Information control group receive mailed packets of information.
Study NCT02159534 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Primebrain
Description: Primebrain stimulation programme aims to facilitate the infant's self-organization of postural competences by proposing varied sensorimotor experiences in a context supporting parent-child interaction.
Study NCT02159534 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Primebrain
Description: Primebrain stimulation programme aims to facilitate the infant's self-organization of postural competences by proposing varied sensorimotor experiences in a context supporting parent-child interaction.
Study NCT01276327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linagliptin/Pioglitazone
Description: Medium dose oral administration
Study NCT03533400 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Jamboxx Respiratory Therapy Device
Description: Jamboxx Respiratory Therapy Device is a novel device that uses interactive gaming to encourage patient compliance with their prescribed respiratory therapy routines. The device consists of a computer game controller with mouthpiece containing a breath flow sensor that connects to a tablet. With the Jamboxx respiratory therapy device, users can choose from a suite of breath controlled respiratory therapy games to guide them through their routines while receiving real-time feedback, and long-term progress tracking.
Study NCT03533400 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Jamboxx Musical Device
Description: Jamboxx musical device is a hands free, breath controlled music device designed for people with quadriplegia. It resembles a common harmonica in that the user slides a mouthpiece along its horizontal axis to change the pitch of the instrument. The device connects to a personal computer via a mini USB to USB cable to interface with software that provides visual feedback for playing notes and sends the information to the computer speakers. The mouthpiece acts as a transducer, changing air pressure created by the user's lungs to a joystick signal to the computer via a differential pressure sensor. The Jamboxx musical device can produce musical sounds of many instruments (trumpet, drums, etc.) in many different scales and in any key
Study NCT03533400 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Jamboxx Musical Device
Description: Jamboxx musical device is a hands free, breath controlled music device designed for people with quadriplegia. It resembles a common harmonica in that the user slides a mouthpiece along its horizontal axis to change the pitch of the instrument. The device connects to a personal computer via a mini USB to USB cable to interface with software that provides visual feedback for playing notes and sends the information to the computer speakers. The mouthpiece acts as a transducer, changing air pressure created by the user's lungs to a joystick signal to the computer via a differential pressure sensor. The Jamboxx musical device can produce musical sounds of many instruments (trumpet, drums, etc.) in many different scales and in any key
Study NCT03861468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Care pathway
Description: Screening for OSA using a combination of bicarbonate assay and STOP-BANG questionnaire and further management by a pneumologist as necessary
Study NCT01423513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fibular Taping
Description: Tape with be applied with tension.
Study NCT01423513 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Taping
Description: Tape will be applied without tension